CSc1nn(Cc2ccc(Br)cc2)c(N(C(C)=O)C(C)=O)c1S(=O)(=O)c1ccccc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?